OverviewChartNewsTraderScreen

BVT Call 140 6MK 20.09.2024/  DE000VD0NMZ4  /

Frankfurt Zert./VONT
6/21/2024  7:48:05 PM Chg.+0.001 Bid9:10:07 AM Ask9:10:07 AM Underlying Strike price Expiration date Option type
0.171EUR +0.59% 0.183
Bid Size: 13,000		 0.204
Ask Size: 13,000		 MERCK CO. D... 140.00 - 9/20/2024 Call
GlobeNewswire 6/18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 6/6 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 6/5 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 6/3 Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
TeleTrader 5/29 Merck to buy biotech firm EyeBio for up to $3B
GlobeNewswire 5/29 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire 5/29 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 5/6 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 5/2 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 4/25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 4/2 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/6 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 3/4 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 2/2 Merck Group to expand investment in South Korea
TeleTrader 2/1 Merck's Q4 sales up 6% to $14.6B
TeleTrader 1/27 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 1/23 Unnatural Products, Inc. Enters Research Collaboration with Merck
GlobeNewswire 12/21/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire 12/19/2023 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...
GlobeNewswire 12/14/2023 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire 12/12/2023 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...
GlobeNewswire 12/5/2023 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...
GlobeNewswire 12/4/2023 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
GlobeNewswire 11/13/2023 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update